|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM286801892 |
| 003 |
DE-627 |
| 005 |
20231225052556.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2019 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.201800662
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n0956.xml
|
| 035 |
|
|
|a (DE-627)NLM286801892
|
| 035 |
|
|
|a (NLM)30039878
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Gu, Zhanjun
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Graphene-Based Smart Platforms for Combined Cancer Therapy
|
| 264 |
|
1 |
|c 2019
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 10.07.2019
|
| 500 |
|
|
|a Date Revised 30.09.2020
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
|
| 520 |
|
|
|a The extensive research of graphene and its derivatives in biomedical applications during the past few years has witnessed its significance in the field of nanomedicine. Starting from simple drug delivery systems, the application of graphene and its derivatives has been extended to a versatile platform of multiple therapeutic modalities, including photothermal therapy, photodynamic therapy, magnetic hyperthermia therapy, and sonodynamic therapy. In addition to monotherapy, graphene-based materials are widely applied in combined therapies for enhanced anticancer activity and reduced side effects. In particular, graphene-based materials are often designed and fabricated as "smart" platforms for stimuli-responsive nanocarriers, whose therapeutic effects can be activated by the tumor microenvironment, such as acidic pH and elevated glutathione (termed as "endogenous stimuli"), or light, magnetic, or ultrasonic stimuli (termed as "exogenous stimuli"). Herein, the recent advances of smart graphene platforms for combined therapy applications are presented, starting with the principle for the design of graphene-based smart platforms in combined therapy applications. Next, recent advances of combined therapies contributed by graphene-based materials, including chemotherapy-based, photothermal-therapy-based, and ultrasound-therapy-based synergistic therapy, are outlined. In addition, current challenges and future prospects regarding this promising field are discussed
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a combined cancer therapy
|
| 650 |
|
4 |
|a graphene-based materials
|
| 650 |
|
4 |
|a smart platforms
|
| 650 |
|
4 |
|a stimuli
|
| 650 |
|
7 |
|a Drug Carriers
|2 NLM
|
| 650 |
|
7 |
|a Graphite
|2 NLM
|
| 650 |
|
7 |
|a 7782-42-5
|2 NLM
|
| 700 |
1 |
|
|a Zhu, Shuang
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yan, Liang
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhao, Feng
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhao, Yuliang
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 31(2019), 9 vom: 24. März, Seite e1800662
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:31
|g year:2019
|g number:9
|g day:24
|g month:03
|g pages:e1800662
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.201800662
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 31
|j 2019
|e 9
|b 24
|c 03
|h e1800662
|